Work

Do elderly chemorefractory NSCLC patients derive benefit from salvage targeted therapy? Subgroup analysis of clinical outcome and toxicity from the BATTLE trial.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.7550

Authors: A. S. Tsao, S. Liu, J. J. Lee, C. M. Alden, E. S. Kim, G. R. Blumenschein, R. S. Herbst, S. M. Lippman, I. I. Wistuba, W. K. Hong

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2567652142

Cites:

Cited by: 1

Related to: 10